Meridian Bioscience OverviewMeridian Bioscience EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VIVO.
Quarterly EBIT
-$28.95M
↓ 240.78% YoY
As of Dec 31, 2022
Annual EBIT (TTM)
$26.09M
↓ 68.85% YoY
Trailing 12 months ending Dec 31, 2022
Meridian Bioscience OverviewEBIT (Earnings Before Interest and Taxes) analysis for VIVO.
As of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022